Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Biolinq Shine, Insulin Icodec, and Eli Lilly's Pipeline
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, explore 3 significant developments shaping diabetes care: a novel glucose-sensing technology, the return of once-weekly insulin icodec to the US Food and Drug Administration (FDA), and changes to Eli Lilly’s metabolic research pipeline.00:00:01 Introduction00:00:18 The Biolinq Shine00:05:59 The Practicality of Monitoring Glucose00:06:55 Wishlist for the Biolinq's Future00:08:38 Insulin Icodec Resubmission00:10:21 Benefits of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.